| Staci Jones Thomas, MD | |
|
608 Cheat Rd, Morgantown, WV 26508-4210 | |
| (304) 594-1313 | |
| (304) 594-2408 |
| Full Name | Staci Jones Thomas |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 608 Cheat Rd, Morgantown, West Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104841527 | NPI | - | NPPES |
| 1808409000 | Medicaid | WV | |
| 404274300 | Medicaid | MD | |
| 1012400040001 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 20750 (West Virginia) | Primary |
| Entity Name | West Virginia University Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275504508 PECOS PAC ID: 1052224565 Enrollment ID: O20031111000207 |
News Archive
Increased procedure volume by both surgeon and hospital are associated with decreased mortality.
Researchers at The Medical Research Council Laboratory of Molecular Biology have conducted a study showing how the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein interacts with host cell factors in ways that promote the formation of syncytia.
In a study focusing on the role of self-donated (autologous) bone marrow-derived endothelial progenitor cells (EPCs) in placental vascular development, researchers in Japan have discovered that when transplanted into pregnant mice, EPCs can contribute to better blood vessel growth that helps in forming "normalized" placental vascularization, leading, in turn, to reduced recurrent miscarriages by providing a healthier fetal environment during gestation.
A team of scientists from the National Cancer Centre Singapore, Duke-NUS Graduate Medical School Singapore, and Taiwan's Chang Gung Memorial Hospital, LinKou, have made a breakthrough in understanding the cancer-promoting action of Aristolochic Acid (AA), a natural product of Aristolochia plants traditionally used in some Asian herbal remedies for weight loss and slimming.
Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR® (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not meet its primary endpoint of improving recurrence-free survival.
› Verified 5 days ago
| Entity Name | West Virginia University Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598847634 PECOS PAC ID: 9537077441 Enrollment ID: O20050404000512 |
News Archive
Increased procedure volume by both surgeon and hospital are associated with decreased mortality.
Researchers at The Medical Research Council Laboratory of Molecular Biology have conducted a study showing how the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein interacts with host cell factors in ways that promote the formation of syncytia.
In a study focusing on the role of self-donated (autologous) bone marrow-derived endothelial progenitor cells (EPCs) in placental vascular development, researchers in Japan have discovered that when transplanted into pregnant mice, EPCs can contribute to better blood vessel growth that helps in forming "normalized" placental vascularization, leading, in turn, to reduced recurrent miscarriages by providing a healthier fetal environment during gestation.
A team of scientists from the National Cancer Centre Singapore, Duke-NUS Graduate Medical School Singapore, and Taiwan's Chang Gung Memorial Hospital, LinKou, have made a breakthrough in understanding the cancer-promoting action of Aristolochic Acid (AA), a natural product of Aristolochia plants traditionally used in some Asian herbal remedies for weight loss and slimming.
Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR® (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not meet its primary endpoint of improving recurrence-free survival.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Staci Jones Thomas, MD Po Box 1127, Morgantown, WV 26507-1127 Ph: (304) 598-4032 | Staci Jones Thomas, MD 608 Cheat Rd, Morgantown, WV 26508-4210 Ph: (304) 594-1313 |
News Archive
Increased procedure volume by both surgeon and hospital are associated with decreased mortality.
Researchers at The Medical Research Council Laboratory of Molecular Biology have conducted a study showing how the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein interacts with host cell factors in ways that promote the formation of syncytia.
In a study focusing on the role of self-donated (autologous) bone marrow-derived endothelial progenitor cells (EPCs) in placental vascular development, researchers in Japan have discovered that when transplanted into pregnant mice, EPCs can contribute to better blood vessel growth that helps in forming "normalized" placental vascularization, leading, in turn, to reduced recurrent miscarriages by providing a healthier fetal environment during gestation.
A team of scientists from the National Cancer Centre Singapore, Duke-NUS Graduate Medical School Singapore, and Taiwan's Chang Gung Memorial Hospital, LinKou, have made a breakthrough in understanding the cancer-promoting action of Aristolochic Acid (AA), a natural product of Aristolochia plants traditionally used in some Asian herbal remedies for weight loss and slimming.
Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals, Inc., an Amgen subsidiary (Nasdaq: AMGN), today announced that a Phase 3 trial evaluating the investigational use of NEXAVAR® (sorafenib) tablets as an adjuvant treatment for patients with hepatocellular carcinoma (HCC), or liver cancer, who had no detectable disease after surgical resection or local ablation, did not meet its primary endpoint of improving recurrence-free survival.
› Verified 5 days ago
Dr. Kathryn S Moffett, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Stadium Drive, Morgantown, WV 26506 Phone: 304-598-4800 Fax: 304-598-6061 | |
Rupesh Kumar Natarajan, Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 304-293-4451 | |
Dr. Melissa Albert, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 1000 Mon Health Medical Park Dr Ste 1202, Morgantown, WV 26505 Phone: 304-599-1975 Fax: 304-599-2705 | |
Dr. Panitan Yossuck, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Stadium Drive, Morgantown, WV 26506 Phone: 304-598-4800 Fax: 304-293-6963 | |
Audra Suzanne Rouster, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, 9214, Morgantown, WV 26506 Phone: 304-293-1017 | |
Martin Edward Weisse, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 304-598-4800 | |
Dr. Shipra Gupta, M.D Pediatrics Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 304-598-4800 |